SP-MHCI-1287-3
The Human HLA class II antigen (Hla histocompatibility antigen, DR beta 5 chain) Peptide (IEDB: 105151) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The HLA class II antigen Peptide, H-DVGEYRAVTELGRPD-OH (Uniprot: Q30154 aa: 72-86) from JPT is produced under strict quality control and quality management.
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References:
Read References with JPT’s Antigen Peptides
HLA class II antigen DR beta 5 chain 72-86, DVGEYRAVTELGRPD has been described in:
Induction of T-cell response to cryptic MHC determinants during allograft rejection., Hum Immunol, 2000 (PMID: 11163093.0)
Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation., J Immunol, 1994 (PMID: 7517977.0)
HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis., Cell, 2020 (PMID: 33091337.0)
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Adenocarcinoma, Autoimmune disease, Breast cancer, Diabetes, Leukemia, Lung cancer, Melanoma, Ovarian cancer |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | HLA class II antigen |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No |
Information | Values |
---|---|
Sequence: | H-DVGEYRAVTELGRPD-OH |
Specifications: | 15mer peptide as TFA salt |
Check our list of products, click and go.
Get a quote